Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 736

1.

Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.

Lanfranchi A, Verardi R, Tettoni K, Neva A, Mazzolari E, Pennacchio M, Pasic S, Ugazio AG, Albertini A, Porta F.

Haematologica. 2000 Nov;85(11 Suppl):41-6.

PMID:
11268323
2.

Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor.

Kawano Y, Takaue Y, Watanabe A, Takeda O, Arai K, Itoh E, Ohno Y, Teshima T, Harada M, Watanabe T, Okamoto Y, Abe T, Kajiume T, Matsushita T, Ikeda K, Endo M, Kuroda Y, Asano S, Tanosaki R, Yamaguchi K, Law P, McMannis JD.

Blood. 1998 Nov 1;92(9):3123-30.

3.

[CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].

Sawada H, Wake A, Yamasaki Y, Izumi Y.

Rinsho Ketsueki. 2000 Jun;41(6):500-6. Japanese.

PMID:
10921350
4.

High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.

Briones J, Urbano-Ispizua A, Lawler M, Rozman C, Gardiner N, Marín P, Salgado C, Féliz P, McCann S, Montserrat E.

Exp Hematol. 1998 May;26(5):415-20.

PMID:
9590658
5.

Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.

Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A.

Pediatrics. 1996 Sep;98(3 Pt 1):420-8.

PMID:
8784367
6.

Long-term follow-up after allogeneic granulocyte colony-stimulating factor--primed bone marrow transplantation.

Isola L, Scigliano E, Fruchtman S.

Biol Blood Marrow Transplant. 2000;6(4A):428-33.

PMID:
10975511
7.

CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.

Kasow KA, Sims-Poston L, Eldridge P, Hale GA.

Biol Blood Marrow Transplant. 2007 May;13(5):608-14. Epub 2007 Mar 23.

8.

Mobilization and selection of peripheral blood hematopoietic progenitors in children with systemic sclerosis.

Locatelli F, Perotti C, Torretta L, Maccario R, Montagna D, Ravelli A, Giorgiani G, De Benedetti F, Giraldi E, Magnani ML, De Stefano P, Martini A.

Haematologica. 1999 Sep;84(9):839-43.

9.

Transplantation of megadoses of purified haploidentical stem cells.

Handgretinger R, Schumm M, Lang P, Greil J, Reiter A, Bader P, Niethammer D, Klingebiel T.

Ann N Y Acad Sci. 1999 Apr 30;872:351-61; discussion 361-2.

PMID:
10372137
10.

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.

Bethge WA, Faul C, Bornhäuser M, Stuhler G, Beelen DW, Lang P, Stelljes M, Vogel W, Hägele M, Handgretinger R, Kanz L.

Blood Cells Mol Dis. 2008 Jan-Feb;40(1):13-9. Epub 2007 Sep 14.

PMID:
17869547
11.

Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.

Knutsen AP, Wall DA.

J Allergy Clin Immunol. 1999 May;103(5 Pt 1):823-32.

PMID:
10329816
12.

Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor.

Arseniev L, Tischler HJ, Battmer K, Südmeier I, Casper J, Link H.

Bone Marrow Transplant. 1994 Nov;14(5):791-7.

PMID:
7534162
13.
14.

A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF.

Isola LM, Scigliano E, Skerrett D, Shank B, Ross V, Najfeld V, Fruchtman S.

Bone Marrow Transplant. 1997 Dec;20(12):1033-7.

15.
16.

Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.

Bielorai B, Trakhtenbrot L, Amariglio N, Rothman R, Tabori U, Dallal I, Golan H, Neumann Y, Reichart M, Kaplinsky C, Rechavi G, Toren A.

Bone Marrow Transplant. 2004 Aug;34(4):317-20.

PMID:
15220954
17.

Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system.

Rowley SD, Loken M, Radich J, Kunkle LA, Mills BJ, Gooley T, Holmberg L, McSweeney P, Beach K, MacLeod B, Appelbaum F, Bensinger WI.

Bone Marrow Transplant. 1998 Jun;21(12):1253-62.

18.

In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID).

Dickinson AM, Reid MM, Abinun M, Peak J, Brigham K, Dunn J, Cant AJ.

Bone Marrow Transplant. 1997 Feb;19(4):323-9.

19.

Allogeneic transplant of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors.

Sandmaier BM, Storb R, Santos EB, Krizanac-Bengez L, Lian T, McSweeney PA, Yu C, Schuening FG, Deeg HJ, Graham T.

Blood. 1996 Apr 15;87(8):3508-13.

20.

The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.

Jiang Z, Adams GB, Hanash AM, Scadden DT, Levy RB.

Biol Blood Marrow Transplant. 2002;8(11):588-96.

PMID:
12463477
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk